Sugi Predict

Sugi Predict / Compounds / SCHEMBL1023596

SCHEMBL1023596

SCHEMBL1023596

OCc1cccc(CBr)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 1/20 0.50
▸ TSHR P16473 2/20 0.48
▸ TRPA1 O75762 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ PRSS1 P07477 1/20 0.47
▸ PRSS2 P07478 1/20 0.47
▸ PRSS3 P35030 1/20 0.47
▸ PRKCI P41743 1/20 0.45
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ S1PR1 P21453 6/20 0.42
▸ DAO P14920 1/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41
▸ NOS3 P29474 2/20 0.40
▸ NOS1 P29475 2/20 0.40
▸ NOS2 P35228 2/20 0.40
▸ CFTR P13569 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348159 0.87 ALDH1A1 (0.61) ENPP2TSHRTRPA1ALDH1A1NOS3
SCHEMBL123838 0.87 TSHR (0.61) ENPP2TSHRPRSS1PRSS2PRSS3
SCHEMBL2213709 0.87 ALDH1A1 (0.61) ENPP2TSHRTRPA1ALDH1A1NOS3
Hydrochloric Acid SCHEMBL14334287 0.84 ENPP2 (0.58) ENPP2TSHRPRSS1PRSS2PRSS3
SCHEMBL31139262 0.82 TSHR (0.57) TSHRMRGPRX4
SCHEMBL1247184 0.81 TDP1 (0.52) TSHRTRPA1ALDH1A1NOS3NOS1
SCHEMBL16942778 0.81 TDP1 (0.52) ENPP2TSHRPRSS1PRSS2PRSS3
SCHEMBL9999688 0.79 ENPP2 (0.54) ENPP2TSHRPRSS1PRSS2PRSS3
SCHEMBL15389994 0.79 TRPA1 (0.52) TSHRTRPA1ALDH1A1PRSS1PRSS2
SCHEMBL1229742 0.78 ACHE (0.48) ENPP2TSHRTRPA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118755242-B Mildew-proof fresh-keeping type packaging bag and preparation method thereof 江苏三之喜新型材料科技有限公司 2025-03-28 — — CN claimed
CN-118755242-A Mildew-proof fresh-keeping type packaging bag and preparation method thereof 江苏三之喜新型材料科技有限公司 2024-10-11 — — CN claimed
US-20250115590-A1 MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF FORESEE PHARMACEUTICALS USA, INC. 2025-04-10 — — US disclosed
CN-118755242-B Mildew-proof fresh-keeping type packaging bag and preparation method thereof 江苏三之喜新型材料科技有限公司 2025-03-28 — — CN disclosed
US-12215096-B2 Matrix metalloproteinase (MMP) inhibitors and methods of use thereof FORESEE PHARMACEUTICALS USA, INC. (US) 2025-02-04 — — US disclosed
CN-118755242-A Mildew-proof fresh-keeping type packaging bag and preparation method thereof 江苏三之喜新型材料科技有限公司 2024-10-11 — — CN disclosed
WO-2024199069-A1 POLYARYL-CONTAINING MACROCYCLIC COMPOUND AND USE THEREOF 浙江养生堂天然药物研究所有限公司 2024-10-03 — — WO disclosed
CN-118724916-A Polyaryl-containing macrocyclic compounds and uses thereof 浙江养生堂天然药物研究所有限公司 2024-10-01 — — CN disclosed
CN-118359546-A Nitric oxide donor type ambrisentan derivative, and pharmaceutical composition and application thereof 江苏海洋大学 2024-07-19 — — CN disclosed
CN-118359595-A Nitric oxide donor type atrasentan derivative, and pharmaceutical composition and application thereof 江苏海洋大学 2024-07-19 — — CN disclosed
CN-117924258-A Pyridone compound derivative and application thereof 复旦大学 2024-04-26 — — CN disclosed
US-20070167443-A1 Substituted quinolones and methods of use CHEMOCENTRYX, INC. (US) 2007-07-19 — — US disclosed
WO-2007059108-A2 SUBSTITUTED QUINOLONES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-24 — — WO disclosed
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 — — US disclosed
US-5747517-A ALZHEIMER'S DISEASE; PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 1998-05-05 — — US disclosed
US-5650408-A Thiazolo benzazepine containing dual action inhibitors BRISTOL-MYERS SQUIBB COMPANY 1997-07-22 — — US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 — — EP disclosed
US-5234946-A Anticholesterol, antilipemic BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-10 — — US disclosed
US-4389410-A Esters of monic acid A useful as antibacterial and antimycoplasmal agents BEECHAM GROUP LIMITED (GB) 1983-06-21 — — US disclosed
EP-0045150-A1 Antibacterial compounds, processes for their preparation and composititions containing them BEECHAM GROUP PLC (GB) 1982-02-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167443-A1 Substituted quinolones and methods of use TOP2A, NQO2, TOP2B ENPP2 1230/4885TSHR 4372/4885TRPA1 4839/4885
US-12215096-B2 Matrix metalloproteinase (MMP) inhibitors and methods of use thereof MMP12, MMP1, MMP11 ENPP2 95/4885TSHR 4265/4885TRPA1 4281/4885
US-20250115590-A1 MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF MMP12, MMP1, MMP11 ENPP2 95/4885TSHR 4265/4885TRPA1 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.